Manipal Health Enterprises Ltd (MANIPALHOS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Manipal Health Enterprises Ltd on NSE and BSE, with an AI summary of each filing.
Press Release- "Thakral leases land to Manipal Hospitals, one of India''s leading hospital chains for developing and operating a multi-speciality hospital as Gurugram, Delhi NCR"
Press Release · 04 Nov 2026, 11:51 pm
Manipal Hospitals Signs 30-Year Gurugram Land Lease with Thakral for 500-Bed Facility On 4th Nov'26, Manipal Health Enterprises entered into a long-term land lease agreement for an initial period of ~30 years with SGX-listed Thakral Corporation's subsidiary, TIL Investments. Under the pact, Manipal will lease ~3.5 acres in Gurugram, Delhi NCR, to develop and operate a multi-speciality hospital in phases. The first phase will feature up to 500 beds, expanding Manipal's existing pan-India footprint of 50 hospitals and 13,400+ licensed beds while anchoring Thakral's mixed-use healthcare and wellness ecosystem.
Reg-30 intimation for execution of lease agreement with TIL Investments Private Limited .
Others (Uncategorized) · 04 Nov 2026, 11:22 pm
Manipal Health Executes Long-Term Land Lease for Gurugram Hospital Development Manipal Health Enterprises Limited has executed a long-term Lease Deed with TIL Investments Private Limited on 4th Nov'26 for land situated at Village Kherki Daula, Tehsil Manesar, District Gurugram, Haryana. The lease has been secured for a tenure of 29 years and 11 months to construct, operate, manage, and maintain a hospital facility. The transaction is not a related-party transaction and confers no special rights beyond customary lease obligations.
Manipal Health Enterprises Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 13 Nov 2026, 5:30 am
Manipal Health Enterprises Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 13 Nov 2026, 5:30 am
Manipal Health Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Prior intimation ....
Intimation · 13 Nov 2026, 5:30 am
Manipal Health Enterprises Board to Consider Q2 FY27 Financial Results Manipal Health Enterprises Limited has scheduled a meeting of its Board of Directors on 13th Nov'26 to consider and approve the standalone and consolidated unaudited financial results, along with the statutory auditor's Limited Review Report, for the quarter and half year ended 30th Sep'26.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
Encumbered Shares - Invocation / Release · 31 Oct 2026, 3:42 pm
MEMG International India Discloses Share Pledge in Manipal Health Enterprises Promoter group entity MEMG International India Pvt Ltd reported the creation of a pledge over 1,44,92,951 equity shares (1.09% of total diluted share capital) of Manipal Health Enterprises Ltd on 24th Oct'26 in favour of Vistra ITCL (India) Ltd as debenture trustee. The pledge secures unlisted, unrated, redeemable NCDs aggregating INR 500 Cr issued by Claypond Capital Partners Pvt Ltd, backing share value of INR 904 Cr (1.81x asset cover) for general corporate purposes and debt management. Total promoter encumbrance stands at 100% of promoter holdings (27.70% total capital).
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 30, 2026 for MEMG International India Pvt Ltd
Encumbered Shares - Invocation / Release · 31 Oct 2026, 3:37 pm
Promoter Group Creates Pledge on Manipal Health Enterprises Shares MEMG International India Private Limited, part of the promoter group of Manipal Health Enterprises Limited, created a pledge over 1,44,92,951 equity shares (1.09% of total diluted share capital; 3.93% of promoter holding) on 24th Oct'26. The pledge was executed in favor of Vistra ITCL (India) Limited as debenture trustee to secure unlisted, unrated, redeemable NCDs aggregating up to INR 500 Crore issued by Claypond Capital Partners Private Limited. The pledged shares are valued at INR 904 Crore, providing an asset cover ratio of 1.81x.
Please find attached the disclosure under Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015 pertaining to actions taken/ order passed against the subsidiary Company.
Others (Uncategorized) · 30 Oct 2026, 10:50 pm
Manipal Health Subsidiary Receives GST Demand and Penalty Orders Totaling Over ₹12.6 Crore Manipal Health Enterprises' subsidiary, Manipal Hospitals Eastern India, received two GST orders from Kolkata tax authorities. The first order, received on 14th Aug'26 for FY 2019-20, confirmed a tax demand of ₹3.78 crore and a penalty of ₹37.75 lakh regarding input tax credit and outward supplies. The second order, received on 11th Sep'26 for FY 2021-22, confirmed a demand of ₹4.23 crore alongside an equivalent penalty of ₹4.23 crore concerning inpatient drug supplies. The company reported no material operational impact and plans to appeal.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 29, 2026 for MEMG International India Pvt Ltd
Encumbered Shares - Invocation / Release · 30 Oct 2026, 3:05 pm
MEMG International India Releases Pledge on 1.09% Stake in Manipal Health Enterprises Promoter group entity MEMG International India Private Limited released a pledge on 1,44,92,951 shares (1.09% of total share capital) of Manipal Health Enterprises Limited on 22nd Oct'26. The transaction comprised the release of 72,50,000 pledged shares from Vistra ITCL (India) Limited and 72,42,951 pledged shares from 360 One Prime Limited. Following the release, MEMG International India retains an encumbered holding of 2,38,20,811 shares (1.79% stake) under preexisting encumbrance covenants.
Please find attached the voting result along with the consolidated scrutinizer report
Annual General Meeting · 02 Oct 2026, 3:57 am
Manipal Health Enterprises 16th AGM Voting Results Disclosed At the 16th AGM on 29th Sep'26, Manipal Health Enterprises shareholders approved 10 of 11 resolutions. Approved proposals include adopting FY26 financials, appointing Price Waterhouse Chartered Accountants LLP as statutory auditors, ratifying ESOP 2024 schemes, fixing a five-year term for Non-Executive Director Dr. Ranjan Ramdas Pai, and amending Articles of Association for board nomination rights to Temasek and MGHS groups. However, Resolution 9, regarding the upside sharing agreement between Manipal Research & Management Services International and TPG SG Magazine Pte. Ltd., failed with 61.99% votes against.
Summary of Proceedings for 16th AGM held on September, 29 2026.
Annual General Meeting · 29 Sept 2026, 10:56 pm
Please find enclosed Proceedings of the 16th Annual General Meeting of the Company held on September 29, 2026.
Annual General Meeting · 29 Sept 2026, 10:46 pm
Please find attached the Press Release.
Press Release · 19 Sept 2026, 1:30 am
Manipal Hospitals Redeems ₹5,310 Crore NCDs via IPO Proceeds Manipal Health Enterprises has fully redeemed outstanding listed NCDs worth ₹5,310 crore issued by subsidiary Manipal Hospitals Private Limited, utilizing its IPO proceeds in line with objects disclosed on 31st Jul'26. The full redemption includes principal, accrued interest, and early redemption costs, significantly reducing interest burden and improving leverage. This follows strong Q1 FY27 results, where revenue surged 38.1% YoY to ₹3,091 crore, EBITDA grew 26.4% YoY to ₹749 crore, PAT stood at ₹243 crore, and adjusted PAT increased 30.9% YoY to ₹332 crore.
Intimation pursuant to Regulation 30 (12) read with Schedule III of the SEBI Listing Regulations.
Others (Uncategorized) · 17 Sept 2026, 1:06 am
Manipal Health Enterprises Redeems Rs. 5,310 Crore NCDs via IPO Proceeds Manipal Health Enterprises Limited utilised IPO proceeds to execute the full redemption of outstanding listed non-convertible debentures (NCDs) issued by its wholly owned subsidiary, Manipal Hospitals Private Limited. The redeemed NCDs carry a nominal value of Rs. 5,310 crore, settled alongside accrued interest and applicable prepayment or early redemption costs. This debt clearance aligns directly with the stated objects of the Initial Public Offering detailed in the company's prospectus dated 31st Jul'26.
Communication to the shareholders on weblink of notice of 16th Annual General Meeting and Annual Report for the financial year 2025-26.
Annual General Meeting · 05 Sept 2026, 2:45 am
Annual Report for the financial year 2025-26 along with Notice convening 16th Annual General Meeting.
Others (Uncategorized) · 05 Sept 2026, 2:26 am
Notice convening the 16th Annual General Meeting along with Annual Report for the financial year 2025-26
Annual General Meeting · 05 Sept 2026, 2:18 am
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September ....
Encumbered Shares - Invocation / Release · 04 Sept 2026, 3:57 pm
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 03, 2026 for Manipal Global ....
Encumbered Shares - Invocation / Release · 04 Sept 2026, 3:43 pm
Manipal Health Enterprises Limited has informed the Exchange about Transcript for the Earnings call with Investors/ Analysts held on August 21, 2026
Transcript · 28 Aug 2026, 2:28 am
Manipal Health Q1 FY27: Volume-Led Growth with Robust Margins Manipal Health reported strong Q1 FY27 results, driven by volume growth. Revenue reached INR 3,091 crores (+38% YoY), with network EBITDA at INR 749 crores (+26% YoY). Excluding a prior-year one-off, EBITDA growth was over 30%. Operating margin stood at 24.2% (25% excluding Sahyadri). Key metrics showed strong performance: inpatient volumes grew 39% YoY, occupancy rose to 65% (+290bps YoY), and ARPOB (ex-Sahyadri) increased 9% YoY to INR 77,200. Sahyadri integration is progressing, with Q1 revenue at INR 332 crores.
Audio Recording of the Earnings call with Analysts/ Investor
Audio / Video · 21 Aug 2026, 11:41 pm
Manipal Hospitals Uploads Analyst & Investor Earnings Call Recording Manipal Health Enterprises (NSE: MANIPALHOS) has uploaded the audio recording of its analyst and investor conference call held on Fri, 21 Aug'26 at 11:00 AM. The recording is available on the company's website under the investor relations section. This filing complies with SEBI's disclosure requirements.
Manipal Health Enterprises Limited has informed the Exchange about change in Management
Change in Management · 21 Aug 2026, 1:43 am
Manipal Health Q1FY27 Results and Key Board Decisions Manipal Health reported Q1FY27 consolidated net profit of ₹243.43 cr, down 4.2% YoY, on revenue of ₹3,090.63 cr, up 38.1% YoY. Standalone PAT was ₹115.53 cr, down 8.3% YoY. The Board approved the results for the quarter ended Jun 30, '26. Key decisions include appointing Price Waterhouse as statutory auditors for a 5-year term, replacing BSR & Co. The Board also approved the re-appointment of directors, an amendment to the Articles of Association, and convening the 16th AGM on Sep 29, '26.
Press Release and Investor Presentation for the Earnings Conference Call with Analysts and Investors of Manipal Health Enterprises Limited (the Company )
Press Release · 21 Aug 2026, 1:13 am
Manipal Hospitals Q1 FY27: Strong Revenue Growth in First Post-IPO Results Manipal Hospitals reported strong Q1 FY27 results, its first since listing. Revenue grew 38.1% YoY to ₹3,091 crore, while EBITDA increased 26.4% YoY to ₹749 crore. Adjusted EBITDA, excluding a Q1 FY26 one-off, grew 29.7% YoY. Adjusted PAT, excluding Sahyadri acquisition NCD interest, rose 30.9% YoY to ₹332 crore. Growth was driven by strong patient demand and capacity absorption, with occupancy rising 290 bps YoY to 65.0%. Gross inpatient revenue from high-acuity CONGO-R specialties grew 45% YoY, with its mix increasing to 65.4%.
Appointment of M/s Price Waterhouse Chartered Accountants LLP, Chartered Accountants as the Statutory Auditors of the Company
Change in Management · 21 Aug 2026, 12:39 am
Manipal Health Q1FY27 Results: Strong Growth Amidst Key Board Changes Manipal Health Enterprises reported solid Q1FY27 consolidated results with revenue from operations at ₹3,090.63 Cr, up 38.1% YoY, and net profit at ₹243.43 Cr, down 4.2% YoY. On a standalone basis, revenue was ₹1,048.30 Cr (+28.2% YoY) with net profit at ₹115.53 Cr (-8.3% YoY). The board approved results for the quarter ending Jun 30, '26, and appointed Price Waterhouse Chartered Accountants as new statutory auditors. Directors Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia were re-appointed. An AGM is scheduled for Sep 29, '26.
Manipal Health Enterprises Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Outcome · 20 Aug 2026, 11:59 pm
Manipal Health Enterprises Limited - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Crore) ■ Revenue: 3,091 (+38.1% YoY | +7.2% QoQ) ■ EBITDA: 737 (+25.6% YoY | +6.6% QoQ) ■ EBITDA Margin (%): 23.8 (-238 bps YoY | -15 bps QoQ) ■ PAT: 232 (-7.5% YoY | +30.4% QoQ) ■ EPS (INR): 1.96 (-9.7% YoY | +28.9% QoQ)